Oct 2020: All 13 participating hospital departments of CLEO study are in intervention phase!

1 okt 2020

13 hospital departments of 3 countries participate in CLEO (Clinical Evaluation of DeltaScan). CLEO has a stepped wedge design, so some departments had a short control phase and a long intervention phase and others the opposite. Since 1 October 2020 all participants are in the control phase, meaning that DeltaScan is used for detection and monitoring for delirium.

This milestone was “celebrated” with an attractively designed 2-page CLEO newsletter, that was sent to all participants. The German centers received it in German language, the Dutch and Belgian centers in Dutch.